242 related articles for article (PubMed ID: 17667940)
21. Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression.
de Bruijn DR; Peters WJ; Chuva de Sousa Lopes SM; van Dijk AH; Willemse MP; Pfundt R; de Boer P; Geurts van Kessel A
Hum Mol Genet; 2006 Oct; 15(19):2936-44. PubMed ID: 16926188
[TBL] [Abstract][Full Text] [Related]
22. APETALA1 and SEPALLATA3 interact with SEUSS to mediate transcription repression during flower development.
Sridhar VV; Surendrarao A; Liu Z
Development; 2006 Aug; 133(16):3159-66. PubMed ID: 16854969
[TBL] [Abstract][Full Text] [Related]
23. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
[TBL] [Abstract][Full Text] [Related]
24. Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.
Zöllner SK; Rössig C; Toretsky JA
Cancer Metastasis Rev; 2015 Sep; 34(3):417-28. PubMed ID: 26277104
[TBL] [Abstract][Full Text] [Related]
25. The function of the Aristaless-related homeobox (Arx) gene product as a transcriptional repressor is diminished by mutations associated with X-linked mental retardation (XLMR).
Fullenkamp AN; El-Hodiri HM
Biochem Biophys Res Commun; 2008 Dec; 377(1):73-8. PubMed ID: 18835247
[TBL] [Abstract][Full Text] [Related]
26. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
27. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
[TBL] [Abstract][Full Text] [Related]
28. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
[TBL] [Abstract][Full Text] [Related]
29. Fusions of the SYT and SSX genes in synovial sarcoma.
Ladanyi M
Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
[TBL] [Abstract][Full Text] [Related]
30. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
[TBL] [Abstract][Full Text] [Related]
31. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
[TBL] [Abstract][Full Text] [Related]
32. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.
Kadoch C; Crabtree GR
Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691
[TBL] [Abstract][Full Text] [Related]
33. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
Peng C; Guo W; Yang Y; Zhao H
Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
[TBL] [Abstract][Full Text] [Related]
35. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus.
Thaete C; Brett D; Monaghan P; Whitehouse S; Rennie G; Rayner E; Cooper CS; Goodwin G
Hum Mol Genet; 1999 Apr; 8(4):585-91. PubMed ID: 10072425
[TBL] [Abstract][Full Text] [Related]
36. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
Perani M; Antonson P; Hamoudi R; Ingram CJ; Cooper CS; Garrett MD; Goodwin GH
J Biol Chem; 2005 Dec; 280(52):42863-76. PubMed ID: 16227627
[TBL] [Abstract][Full Text] [Related]
37. Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma.
Raquib AR; Hofvander J; Ta M; Nielsen TO
Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):531-539. PubMed ID: 35880992
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel SSX1 fusions in synovial sarcoma.
Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
[TBL] [Abstract][Full Text] [Related]
39. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.
Chuang HC; Hsu SC; Huang CG; Hsueh S; Ng KF; Chen TC
Pathol Int; 2013 Dec; 63(12):573-80. PubMed ID: 24422953
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K
Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]